Given prior evidence that an affected woman conveys a higher risk of ovarian cancer to her sister than to her mother, we hypothesized that there exists an X-linked variant evidenced by transmission to a woman from her paternal grandmother via her father. We ascertained 3,499 grandmother/granddaughter pairs from the Familial Ovarian Cancer Registry at the Roswell Park Cancer Institute observing 892 informative pairs with 157 affected granddaughters. We performed germline X-chromosome exome sequencing on 186 women with ovarian cancer from the registry. The rate of cancers was 28.4% in paternal grandmother/granddaughter pairs and 13.9% in maternal pairs consistent with an X-linked dominant model (Chi-square test X2 = 0.02, p = 0.89) and incons...
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the averag...
Ovarian cancer is a heterogeneous disease. Data regarding familial risks for specific proband, age a...
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the averag...
<div><p>Given prior evidence that an affected woman conveys a higher risk of ovarian cancer to her s...
SummaryTo establish the contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cance...
Abstract We investigated the prevalence of germline BRCA mutations in a population‐based cohort of A...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
This observational study aimed to investigate whether the reported association between family histor...
This observational study aimed to investigate whether the reported association between family histor...
Overall, 5-10% of primary breast cancer (BC) are inherited and about 15-20% are familial. BRCA1/2 ge...
Breast cancer is the most common malignancy among women in the western world. Most cases are sporadi...
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the averag...
Background: A subsets of ovarian carcinomas (OCs) are related to inherited conditions including Here...
Family history has long been recognized to be a potent risk factor for breast cancer [1]. Family his...
IntroductionThe long-term risk of cancer among first-degree relatives of ovarian cancer patients, es...
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the averag...
Ovarian cancer is a heterogeneous disease. Data regarding familial risks for specific proband, age a...
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the averag...
<div><p>Given prior evidence that an affected woman conveys a higher risk of ovarian cancer to her s...
SummaryTo establish the contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cance...
Abstract We investigated the prevalence of germline BRCA mutations in a population‐based cohort of A...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
This observational study aimed to investigate whether the reported association between family histor...
This observational study aimed to investigate whether the reported association between family histor...
Overall, 5-10% of primary breast cancer (BC) are inherited and about 15-20% are familial. BRCA1/2 ge...
Breast cancer is the most common malignancy among women in the western world. Most cases are sporadi...
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the averag...
Background: A subsets of ovarian carcinomas (OCs) are related to inherited conditions including Here...
Family history has long been recognized to be a potent risk factor for breast cancer [1]. Family his...
IntroductionThe long-term risk of cancer among first-degree relatives of ovarian cancer patients, es...
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the averag...
Ovarian cancer is a heterogeneous disease. Data regarding familial risks for specific proband, age a...
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the averag...